PFIZER INC - 17 Mar 2023 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
10%+ Owner
Signature
/s/ Susan Grant, Assistant Secretary
Issuer symbol
PYXS
Transactions as of
17 Mar 2023
Net transactions value
+$4,999,999
Form type
4
Filing time
21 Mar 2023, 18:07:27 UTC
Previous filing
29 Dec 2022
Next filing
30 Mar 2023
SEC
View on sec.gov
This filing has been restated, see here for the amended filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PYXS Common Stock, $0.001 par value per share Purchase $4,999,999 +1,811,594 +44% $2.76 5,952,263 17 Mar 2023 Direct
holding PYXS Common Stock, $0.001 par value per share 1,080,507 17 Mar 2023 By Pfizer Ventures (US) LLC F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are owned directly by Pfizer Ventures (US) LLC, which is a wholly owned subsidiary of Pfizer Inc.